Pv. Escriba et al., INCREASED DENSITY OF GUANINE-NUCLEOTIDE - BINDING-PROTEINS IN THE POSTMORTEM BRAINS OF HEROIN-ADDICTS, Archives of general psychiatry, 51(6), 1994, pp. 494-501
Objective: To directly evaluate the guanine nucleotide-binding (G) pro
tein subunits alpha, beta, and gamma, which are involved in the signal
transduction of opioid receptors, in the postmortem brains of heroin
addicts who had died of an opiate overdose. Methods: Specimens of the
frontal cortex (Brodmann's area 9) were collected from 11 heroin addic
ts and 10 control subjects without a history of drug abuse. The bioche
mical status of human brain G protein subunits during opiate dependenc
e was studied by means of immunoblotting techniques. Solubilized G pro
teins were separated by gel electrophoresis, transferred to pyroxylin
membranes (western blotting) labeled with specific antiserum samples,
and quantitated by image analysis after enhanced chemoluminescence. Re
sults: In the frontal cortex, relevant increases in the immunoreactivi
ties of G alpha i(1/2) (19% +/- 4%, P<.005), G alpha o (29% +/- 7%, P<
.005), and G alpha s (26% +/- 5%, P<.005) but not of G alpha i(3) were
found in heroin addicts compared with age- and sex-matched controls.
Moreover, the amount of G protein beta-subunit immunoreactivity was al
so consistently increased (27% +/- 8%, P<.01) compared with controls i
n the same brain region. These G protein changes in the brains of huma
n opiate addicts paralleled (with the exception of G alpha s) those ob
tained in the brains of morphine hydrochloride-dependent rats. The inc
rease in G alpha s immunoreactivity that was observed in the rat brain
only after the short-term morphine administration (24% +/- 3%, P<.005
) suggests that the increase in G alpha s immunoreactivity in the brai
ns of human addicts could be the cellular response to a deadly overdos
e of heroin. Conclusions: Alterations in the density of specific Gi an
d Go protein subunits that are coupled to mu-opioid and other opioid r
eceptors may be of clinical relevance in opiate tolerance, dependence,
and abstinence syndrome.